Windlas Biotech Ltd Performance
Day's Low
Day's High
₹861₹895.652 Week's Low
52 Week's High
₹311.6₹952.1
| Returns % | |
| 1 Month Return | -3.45 % |
| 3 Month Return | + 21.5 % |
| 1 Year Return | + 135.59 % |
| Market Stats | |
| Previous Close | ₹863.55 |
| Open | ₹869.00 |
| Volume | 45.29K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,804.85Cr |
Windlas Biotech Ltd Key Statistics
| P/E Ratio | 30.14 |
| PEG Ratio | 3.93 |
| Market Cap | ₹1,804.85 Cr |
| P/B Ratio | 2.37 |
| EPS | 27.98 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 13.63 |
Windlas Biotech Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,804.85 Cr | 22.42% | 0.51 | ₹58 Cr | ₹630 Cr | |
| NA | ₹13,309.24 Cr | 1.24% | 0.00 | ₹97 Cr | ₹4,178 Cr | |
| NA | ₹4,324.62 Cr | 252.38% | 0.51 | NA | NA | |
| NA | ₹2,031.95 Cr | 7.93% | 0.69 | ₹21 Cr | ₹304 Cr | |
| NA | ₹62.76 Cr | 239.45% | 0.75 | NA | NA |
About Windlas Biotech Ltd
Share Price: ₹883.95 per share as on 04 Oct, 2024 04:01 PM
Market Capitalisation: ₹1,804.85Cr as of today
Revenue: ₹175.15Cr as on June 2024 (Q2 24)
Net Profit: ₹13.48Cr as on June 2024 (Q2 24)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
| Organisation | Windlas Biotech Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Windlas Biotech Ltd
Windlas Biotech Shares Surge 27% in a Month - 07 Jun, 2024
Windlas Biotech shares have gained 27% in the past month, with an annual gain of 142%. Despite a P/E ratio of 23.8x, it may still be a buy compared to other Indian companies. The company has been growing earnings rapidly, which could explain its limited P/E. Investors hope for sustained strong earnings performance.
Windlas Biotech Reports Strong Q4 Results - 23 May, 2024
Windlas Biotech's Q4 results show significant YoY growth in revenue and profit, with an EPS of ₹8.14 for Q4, up by 51.25% YoY. The stock has also delivered strong returns over various periods.
Windlas Biotech Reports Strong Financial Results - 20 May, 2024
Windlas Biotech reports strong financial results for FY23-24, with increased sales, revenue, and net income. The company also sees growth in Q4 FY23-24, with rising revenue and net profit.
Insights on Windlas Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 1.18% to 1.59% in Jun 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, WINDLAS stock has moved up by 4.0%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 24.19% to 25.55% in Jun 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 7 quarters, 121.87 Cr → 179.29 Cr (in ₹), with an average increase of 6.1% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 62.82% to 62.51% in Jun 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 10.37% to 8.70% in Jun 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 16.99 Cr → 13.48 Cr (in ₹), with an average decrease of 20.7% per quarter
Windlas Biotech Ltd Financials
Index Inclusions
Windlas Biotech Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 62.51% | ||
| Foreign Institutions | 1.59% | 35.04 | |
| Mutual Funds | 8.7% | ||
| Retail Investors | 25.55% | 5.63 | |
| Others | 1.65% | 13.86 |
Windlas Biotech Ltd Key Indicators
Windlas Biotech Ltd Valuation
Windlas Biotech Ltd in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (30.14x)
October 3, 2024
Industry (58.08x)
October 3, 2024
Highest (31.95x)
September 11, 2024
Windlas Biotech Ltd Earnings and Dividends
Windlas Biotech Ltd Earnings Results
Windlas Biotech Ltd’s net profit jumped 11.68% since last year same period to ₹13.48Cr in the Q1 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated -20.66% fall in its net profits since last 3-months.
Read More about Earnings ResultsWindlas Biotech Ltd Dividends May,2024
In the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.62%.
Read More about Dividends
Windlas Biotech Ltd Technicals Summary
Bearish
Neutral
Bullish
Windlas Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Windlas Biotech Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Windlas Biotech Ltd shares.
Windlas Biotech Ltd (WINDLAS) share price today is ₹883.95
Windlas Biotech Ltd is listed on NSE
Windlas Biotech Ltd is listed on BSE
- Today’s highest price of Windlas Biotech Ltd is ₹895.6.
- Today’s lowest price of Windlas Biotech Ltd is ₹861.
PE Ratio of Windlas Biotech Ltd is 30.14
PE ratio = Windlas Biotech Ltd Market price per share / Windlas Biotech Ltd Earnings per share
Today’s traded volume of Windlas Biotech Ltd(WINDLAS) is 45.29K.
Today’s market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹1804.85Cr.
| Windlas Biotech Ltd(WINDLAS | Price |
|---|---|
52 Week High | ₹952.1 |
52 Week Low | ₹311.6 |
Windlas Biotech Ltd(WINDLAS) share price is ₹883.95. It is down -7.16% from its 52 Week High price of ₹952.1
Windlas Biotech Ltd(WINDLAS) share price is ₹883.95. It is up 183.68% from its 52 Week Low price of ₹311.6
| Windlas Biotech Ltd(WINDLAS | Returns |
|---|---|
1 Day Returns | 20.4% |
1 Month Returns | -3.45% |
3 Month Returns | 21.5% |
1 Year Returns | 135.59% |